Publication details
Léčba erlotinibem nemocných s nemalobuněčným karcinomem plic - efekt snížené dávky při závažných nežádoucích účincích.
| Title in English | Erlotinib treatment in patient with non-small cell lung cancer (NSCLC): The Effect of lowered dose in serious adverse events |
|---|---|
| Authors | |
| Year of publication | 2010 |
| Type | Article in Proceedings |
| Conference | XXXIV. Brněnské onkologické dny sborník |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | Erlotinib; NSCLC; serious adverse events; lowered dose |
| Description | The authors discuss Erlotinib treatment in patient with non-small cell lung cancer (NSCLC)and the effect of lowered dose in case of serious adverse events. |
| Related projects: |